BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6190203)

  • 1. Chemotherapeutic efficacy of Nocodazole encapsulated in liposomes on L1210 murine leukemia.
    Laduron C; Coune A; Atassi G; Hildebrand J; Ruysschaert JM; Stryckmans P; Brassinne C
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):419-36. PubMed ID: 6190203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.
    Brassinne C; Atassi G; Frühling J; Penasse W; Coune A; Hildebrand J; Ruysschaert JM; Laduron C
    J Natl Cancer Inst; 1983 Jun; 70(6):1081-6. PubMed ID: 6574278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocodazole entrapped into liposomes: no more effect on human CFU-C than free nocodazole.
    Loos M; Delforge A; Mattelaer M; Laduron C; Brassinne C; Hildebrand J; Stryckmans P
    Anticancer Res; 1981; 1(6):393-6. PubMed ID: 7344613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
    Allen TM; Mehra T; Hansen C; Chin YC
    Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influencing factors in the leakage of liposome and arabinoside cytosine (ARA-C) entrapped in liposomes in treatment of L1210 mouse leukemia].
    Fu NW
    Zhonghua Zhong Liu Za Zhi; 1985 Jul; 7(4):250-3. PubMed ID: 4085312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and antitumor activity of cis-bis-cyclopentenecarboxylato-1,2-diaminocyclohexane platinum(II) encapsulated in multilamellar vesicles.
    Perez-Soler R; Khokhar AR; Hacker MP; Lopez-Berestein G
    Cancer Res; 1986 Dec; 46(12 Pt 1):6269-73. PubMed ID: 3779646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.
    Rahman A; White G; More N; Schein PS
    Cancer Res; 1985 Feb; 45(2):796-803. PubMed ID: 3967247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved safety, pharmacokinetics and therapeutic efficacy profiles of a novel liposomal formulation of mitoxantrone.
    Gokhale PC; Pei J; Zhang C; Ahmad I; Rahman A; Kasid U
    Anticancer Res; 2001; 21(5):3313-21. PubMed ID: 11848489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular penetration of liposomes containing a water insoluble antimitotic drug in L1210 cells.
    Frühling J; Penasse W; Laurent G; Brassionne C; Hildebrand J; Vanhaelen M; Vanhaelen-Fastre R; Deleers M; Ruysschaert JM
    Eur J Cancer (1965); 1980 Nov; 16(11):1409-16. PubMed ID: 7227417
    [No Abstract]   [Full Text] [Related]  

  • 10. Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.
    Tardi P; Choice E; Masin D; Redelmeier T; Bally M; Madden TD
    Cancer Res; 2000 Jul; 60(13):3389-93. PubMed ID: 10910044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.
    Lim HJ; Masin D; Madden TD; Bally MB
    J Pharmacol Exp Ther; 1997 Apr; 281(1):566-73. PubMed ID: 9103545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.
    Mayer LD; Bally MB; Loughrey H; Masin D; Cullis PR
    Cancer Res; 1990 Feb; 50(3):575-9. PubMed ID: 2297698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R; Khokhar AR; Lopez-Berestein G
    Cancer Res; 1987 Dec; 47(24 Pt 1):6462-6. PubMed ID: 3315188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.
    Rustum YM; Dave C; Mayhew E; Papahadjopoulos D
    Cancer Res; 1979 Apr; 39(4):1390-5. PubMed ID: 421223
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects on the monocyte-macrophage system and antitumor activity against L1210 leukemia of cis-bis-cyclopentenecarboxylato-trans-R,R-1,2-diaminocyclohexane -platinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R; Khokhar AR; Claringbold P; Kasi LP; Lopez-Berestein G
    J Natl Cancer Inst; 1986 Nov; 77(5):1137-43. PubMed ID: 2430132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of central nervous system leukemia in mice by liposome-entrapped 1-beta-D-arabinofuranosylcytosine.
    Hong F; Mayhew E
    Cancer Res; 1989 Sep; 49(18):5097-102. PubMed ID: 2766280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.
    Ganapathi R; Krishan A; Wodinsky I; Zubrod CG; Lesko LJ
    Cancer Res; 1980 Mar; 40(3):630-3. PubMed ID: 7471083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
    Perez-Soler R; Priebe W
    Cancer Res; 1990 Jul; 50(14):4260-6. PubMed ID: 2194651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.
    Schott H; Schwendener RA
    Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of selenium on the growth of L1210 leukemic cells.
    Milner JA; Hsu CY
    Cancer Res; 1981 May; 41(5):1652-6. PubMed ID: 7214335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.